NCT07261228 The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
| NCT ID | NCT07261228 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Chulalongkorn Memorial Hospital |
| Condition | Carbon Footprint in Upper GI Endoscopy |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2025-06-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the carbon footprint produced from diagnostic upper GI endoscopy in patients with dyspepsia and therapeutic upper GI endoscopy in patients with non-variceal upper GI bleeding. The main question it aims to answer is: • How much carbon footprint is generated from upper GI endoscopy Participants are already receiving diagnostic and therapeutic upper GI endoscopy as part of their regular medical care for dyspepsia and non-variceal upper GI bleeding, respectively. The carbon footprint generated from this treatment process is examined.
Eligibility Criteria
Inclusion Criteria: * Patients with dyspepsia or non-variceal upper GI bleeding * Age 20-80 years * Body mass index of 30 or less; * Receiving one of the following procedure during upper GI endoscopy: For diagnostic endoscopy: Rapid urease test for H. pylori infection For therapeutic endoscopy: stop bleeding with either Argon plasma coagulation or Bipolar hemostasis probe or Hemostasis clip Exclusion Criteria: * Platelet \< 50,000 * INR \> 2.5 * Pregnancy * History of allergy to IV sedative medication * Peptic ulcer grade IIc and III according to Forrest classification * Patient receiving inhalation anesthesia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07261228 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Carbon Footprint in Upper GI Endoscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07261228 currently recruiting?
Yes, NCT07261228 is actively recruiting participants. Contact the research team at ponthakorn.pi@gmail.com for enrollment information.
Where is the NCT07261228 trial being conducted?
This trial is being conducted at Bangkok, Thailand, Nakhon Sawan, Thailand.
Who is sponsoring the NCT07261228 clinical trial?
NCT07261228 is sponsored by King Chulalongkorn Memorial Hospital. The trial plans to enroll 75 participants.